Light up ADHD: II. Neuropharmacological effects measured by near infrared spectroscopy: is there a biomarker?

Silvia Grazioli, Maddalena Mauri, Alessandro Crippa, Eleonora Maggioni, Massimo Molteni, Paolo Brambilla, Maria Nobile

Research output: Contribution to journalReview article

Abstract

Background: Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by deficits in self-controlling attention, behavior, and emotions. In recent years, noninvasive optical techniques, such as near infrared spectroscopy (NIRS), have been used to measure the neural correlates of pharmacological-therapy outcomes in children and adolescents with ADHD. Methods: We reviewed a short series of articles that investigated the results of functional NIRS (fNIRS) on developmental-age ADHD. The review was limited to fNIRS studies that investigated the cortical responses that occurred during neuropsychological tasks in ADHD patients who received methylphenidate or atomoxetine. Results: The majority of the reviewed studies revealed the presence of increased oxygenated hemoglobin concentrations in the prefrontal cortex following pharmacotherapy in ADHD samples. A higher frequency of right-lateralized results was found. Limitations: The considered studies are characterized by substantial methodological heterogeneity in terms of the patients’ medication status and washout period, explored cerebral regions, and neuropsychological tasks. Conclusions: fNIRS seems to be a promising tool for the detection of pharmacological-treatment biomarkers in samples of children and adolescents with ADHD.

LanguageEnglish
Pages100-106
Number of pages7
JournalJournal of Affective Disorders
Volume244
DOIs
Publication statusPublished - 2019

Fingerprint

Near-Infrared Spectroscopy
Attention Deficit Disorder with Hyperactivity
Biomarkers
Light
Pharmacological Biomarkers
Methylphenidate
Prefrontal Cortex
Emotions
Hemoglobins
Pharmacology
Drug Therapy
Therapeutics

Keywords

  • ADHD
  • Biomarker
  • fNIRS
  • Pharmachological-treatment
  • Rehabilitation

ASJC Scopus subject areas

  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Light up ADHD : II. Neuropharmacological effects measured by near infrared spectroscopy: is there a biomarker? / Grazioli, Silvia; Mauri, Maddalena; Crippa, Alessandro; Maggioni, Eleonora; Molteni, Massimo; Brambilla, Paolo; Nobile, Maria.

In: Journal of Affective Disorders, Vol. 244, 2019, p. 100-106.

Research output: Contribution to journalReview article

Grazioli, Silvia ; Mauri, Maddalena ; Crippa, Alessandro ; Maggioni, Eleonora ; Molteni, Massimo ; Brambilla, Paolo ; Nobile, Maria. / Light up ADHD : II. Neuropharmacological effects measured by near infrared spectroscopy: is there a biomarker?. In: Journal of Affective Disorders. 2019 ; Vol. 244. pp. 100-106.
@article{d6a13c4ec958438eabb4367546a05981,
title = "Light up ADHD: II. Neuropharmacological effects measured by near infrared spectroscopy: is there a biomarker?",
abstract = "Background: Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by deficits in self-controlling attention, behavior, and emotions. In recent years, noninvasive optical techniques, such as near infrared spectroscopy (NIRS), have been used to measure the neural correlates of pharmacological-therapy outcomes in children and adolescents with ADHD. Methods: We reviewed a short series of articles that investigated the results of functional NIRS (fNIRS) on developmental-age ADHD. The review was limited to fNIRS studies that investigated the cortical responses that occurred during neuropsychological tasks in ADHD patients who received methylphenidate or atomoxetine. Results: The majority of the reviewed studies revealed the presence of increased oxygenated hemoglobin concentrations in the prefrontal cortex following pharmacotherapy in ADHD samples. A higher frequency of right-lateralized results was found. Limitations: The considered studies are characterized by substantial methodological heterogeneity in terms of the patients’ medication status and washout period, explored cerebral regions, and neuropsychological tasks. Conclusions: fNIRS seems to be a promising tool for the detection of pharmacological-treatment biomarkers in samples of children and adolescents with ADHD.",
keywords = "ADHD, Biomarker, fNIRS, Pharmachological-treatment, Rehabilitation",
author = "Silvia Grazioli and Maddalena Mauri and Alessandro Crippa and Eleonora Maggioni and Massimo Molteni and Paolo Brambilla and Maria Nobile",
year = "2019",
doi = "10.1016/j.jad.2018.10.100",
language = "English",
volume = "244",
pages = "100--106",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",

}

TY - JOUR

T1 - Light up ADHD

T2 - Journal of Affective Disorders

AU - Grazioli, Silvia

AU - Mauri, Maddalena

AU - Crippa, Alessandro

AU - Maggioni, Eleonora

AU - Molteni, Massimo

AU - Brambilla, Paolo

AU - Nobile, Maria

PY - 2019

Y1 - 2019

N2 - Background: Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by deficits in self-controlling attention, behavior, and emotions. In recent years, noninvasive optical techniques, such as near infrared spectroscopy (NIRS), have been used to measure the neural correlates of pharmacological-therapy outcomes in children and adolescents with ADHD. Methods: We reviewed a short series of articles that investigated the results of functional NIRS (fNIRS) on developmental-age ADHD. The review was limited to fNIRS studies that investigated the cortical responses that occurred during neuropsychological tasks in ADHD patients who received methylphenidate or atomoxetine. Results: The majority of the reviewed studies revealed the presence of increased oxygenated hemoglobin concentrations in the prefrontal cortex following pharmacotherapy in ADHD samples. A higher frequency of right-lateralized results was found. Limitations: The considered studies are characterized by substantial methodological heterogeneity in terms of the patients’ medication status and washout period, explored cerebral regions, and neuropsychological tasks. Conclusions: fNIRS seems to be a promising tool for the detection of pharmacological-treatment biomarkers in samples of children and adolescents with ADHD.

AB - Background: Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by deficits in self-controlling attention, behavior, and emotions. In recent years, noninvasive optical techniques, such as near infrared spectroscopy (NIRS), have been used to measure the neural correlates of pharmacological-therapy outcomes in children and adolescents with ADHD. Methods: We reviewed a short series of articles that investigated the results of functional NIRS (fNIRS) on developmental-age ADHD. The review was limited to fNIRS studies that investigated the cortical responses that occurred during neuropsychological tasks in ADHD patients who received methylphenidate or atomoxetine. Results: The majority of the reviewed studies revealed the presence of increased oxygenated hemoglobin concentrations in the prefrontal cortex following pharmacotherapy in ADHD samples. A higher frequency of right-lateralized results was found. Limitations: The considered studies are characterized by substantial methodological heterogeneity in terms of the patients’ medication status and washout period, explored cerebral regions, and neuropsychological tasks. Conclusions: fNIRS seems to be a promising tool for the detection of pharmacological-treatment biomarkers in samples of children and adolescents with ADHD.

KW - ADHD

KW - Biomarker

KW - fNIRS

KW - Pharmachological-treatment

KW - Rehabilitation

UR - http://www.scopus.com/inward/record.url?scp=85054742200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054742200&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2018.10.100

DO - 10.1016/j.jad.2018.10.100

M3 - Review article

VL - 244

SP - 100

EP - 106

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

SN - 0165-0327

ER -